Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Trends Supporting 5.7% CAGR Growth Through 2030

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Forecast: What Value Will The Market Reach By 2030?

The chronic obstructive pulmonary disease (copd) and asthma devices market has shown substantial growth over recent years. This market is anticipated to expand from $47.56 billion in 2025 to $50.3 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.8%. The historical rise in this market can be attributed to the increasing prevalence of asthma and COPD, heightened air pollution and smoking rates, a growing reliance on inhalation therapy, the expansion of respiratory care services, and improvements in the diagnosis of chronic respiratory diseases.

The chronic obstructive pulmonary disease (copd) and asthma devices market is poised for substantial growth over the next few years. It is projected to expand to $62.83 billion in 2030, achieving a compound annual growth rate (CAGR) of 5.7%. This anticipated expansion can be attributed to several factors, such as an aging population facing higher respiratory risks, an increasing need for home care respiratory equipment, heightened awareness regarding early management of respiratory conditions, the spread of chronic disease management initiatives, and improved access to respiratory care in emerging markets. Significant trends expected during this forecast period encompass the rising adoption of home-based respiratory care devices, a growing demand for portable and user-friendly inhalation devices, an intensified focus on long-term disease management solutions, an expansion of device utilization across pediatric and geriatric demographics, and an increased emphasis on treatment adherence and symptom control.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=26415768&type=smp&name=Chronic%20Obstructive%20Pulmonary%20Disease%20%28COPD%29%20And%20Asthma%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Growth Factors Behind Sustained Expansion

The increasing occurrence of respiratory conditions is projected to drive the expansion of the chronic obstructive pulmonary disease (COPD) and asthma devices market in the future. These diseases cover numerous ailments impacting the lungs and respiratory systems, including asthma, chronic obstructive pulmonary disease, pneumonia, and lung cancer, which hinder breathing and general respiratory function. The rising incidence of respiratory illnesses stems from heightened air pollution, shifting climate patterns influencing allergens and pathogens, and lifestyle choices like smoking that impair respiratory well-being. COPD and asthma devices are vital for the thorough management and treatment of these respiratory conditions, helping patients attain improved respiratory health and boost their overall quality of life. For example, data from December 2023, sourced from the National Center for Biotechnology Information, a US-based government agency, indicated that the count of COPD cases was anticipated to increase by 112 million, summing up to 592 million by 2050, constituting 9.5% of the eligible demographic. Consequently, the expanding occurrence of respiratory diseases fuels the expansion of the chronic obstructive pulmonary disease (COPD) and asthma devices markets.

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Segment Analysis: What Are The Core Market Categories?

The chronic obstructive pulmonary disease (copd) and asthma devices market covered in this report is segmented –

1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types

2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease

3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications

4) By End User: Pediatric, Adult, Geriatric

Subsegments:

1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI

2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI

3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices

4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers

5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers

6) By Other Types: Nebulizer Accessories, Spacer Devices

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Industry Trends Fueling Future Revenue Growth

Leading companies in the chronic obstructive pulmonary disease and asthma devices market are concentrating on developing innovative solutions, such as intelligent, sensor-enabled inhaler technologies. These advancements aim to enhance medication adherence, facilitate real-time symptom tracking, and support personalized management of respiratory diseases. Such smart inhaler technologies integrate embedded sensors and digital connectivity features to capture inhalation data, monitor patient usage patterns, and deliver actionable insights to both patients and clinicians. For example, in July 2023, Teva UK Ltd., a UK-based pharmaceutical company, introduced the GoResp Digihaler. This digitally connected inhaler is engineered to record inhalation parameters, provide real-time feedback, and foster improved disease control through data-driven patient engagement. The device contributes to better treatment outcomes by enabling remote monitoring, offering clinicians greater insight into patient adherence trends, and strengthening long-term disease management for individuals affected by chronic respiratory conditions.

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Analysis Of Leading Industry Participants

Major companies operating in the chronic obstructive pulmonary disease (copd) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Omron Corporation, Smiths Medical Inc., Cipla Ltd., Chiesi Farmaceutici SpA, Sunovion Pharmaceuticals Inc., Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd., 3M Health Care, Vyaire Medical Inc., Aerogen Ltd

View The Full Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report:

https://thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-and-asthma-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Geographic Spread And Regional Opportunities

North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2025. The regions covered in the chronic obstructive pulmonary disease (copd) and asthma devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model